STOCK TITAN

Curaleaf to Report First Quarter 2024 Financial and Operational Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Curaleaf Holdings, Inc. will report its Q1 2024 financial results on May 9, 2024, followed by a conference call and webcast. Interested individuals can access a replay of the call until May 16, 2024.
Positive
  • None.
Negative
  • None.

NEW YORK, April 4, 2024 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the first quarter ended March 31, 2024 after market close on May 9, 2024.

Management will host a conference call and audio webcast that afternoon at 5:00 p.m. ET consisting of prepared remarks followed by a question-and-answer session related to the Company's operational and financial highlights.

Event:














Curaleaf First Quarter 2024 Financial Earnings Conference Call

Date:














Thursday, May 9, 2024

Time:














5:00 p.m. ET

Live Call:














+1-844-512-2926 (U.S.), +1-416-639-5883 (Canada) or +1-412-317-6300 (International)

Passcode:














7489402

Webcast:














https://ir.curaleaf.com/events
















For interested individuals unable to join the conference call, a dial-in replay of the call will be available until May 16, 2024, and can be accessed by dialing +1-877-344-7529 (U.S.), +1-855-669-9658 (Canada) or +1-412-317-0088 (International) and entering replay pin number: 7935470

About Curaleaf Holdings

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.

Curaleaf IR Twitter Account: https://twitter.com/Curaleaf_IR    

Investor Relations Website: https://ir.curaleaf.com/

Investor Contact:                                                                                                                                                       
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer 
IR@curaleaf.com

Media Contact: 
Curaleaf Holdings, Inc.
Tracy Brady, SVP Corporate Communications
media@curaleaf.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/curaleaf-to-report-first-quarter-2024-financial-and-operational-results-302108534.html

SOURCE Curaleaf Holdings, Inc.

FAQ

When will Curaleaf report its Q1 2024 financial results?

Curaleaf will report its Q1 2024 financial results on May 9, 2024.

What time will the conference call take place?

The conference call will take place at 5:00 p.m. ET on May 9, 2024.

How can I access the live call?

You can access the live call by dialing +1-844-512-2926 (U.S.), +1-416-639-5883 (Canada), or +1-412-317-6300 (International).

Is there a webcast available for the event?

Yes, a webcast will be available at https://ir.curaleaf.com/events.

How long will the replay of the call be available?

The replay of the call will be available until May 16, 2024.

CURALEAF HLDGS INC

OTC:CURLF

CURLF Rankings

CURLF Latest News

CURLF Stock Data

1.30B
411.16M
29.87%
1.38%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
New York